Dr. Susan Weiss, Cannabis Research and Policy: State of the Science

October 2021

Dr. Susan Weiss is the Director, Division of Extramural Research at the National Institute on Drug Abuse (NIDA), which oversees NIDA’s extramural programs, operations planning, and trans-NIH initiatives, such as the Adolescent Brain Cognitive Development (ABCD®) and HEALthy Brain Child Development (HBCD) studies, and the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative. Dr. Weiss also serves as a senior science advisor to the NIDA Director and scientific liaison to the NIH, HHS, and other Federal Agencies. Previously, she served as the Chief of the Science Policy Branch and Acting Director of NIDA’s Office of Science Policy and Communications.

Before coming to NIDA, Dr. Weiss was the Senior Director of Research at the National Mental Health Association (now Mental Health America), and previously she directed a translational research program in the Biological Psychiatry Branch of the National Institute of Mental Health.

Dr. Weiss received multiple awards, including NIH Plain Language Awards, NIH and NIDA Director’s Awards, and an Emmy for her contributions to the HBO Addiction Project. She has published more than 150 scientific articles and chapters, graduated from the State University of New York at Stony Brook, and received her Ph.D. in Psychology from the University of Maryland.

Previous Webinars

TBA

The next Plant Science and Cultivation Series Webinar will be held in May. Please stay tuned!

Read More »

Andrew Kesner, PhD

Preclinical modeling of spontaneous Δ-9-THC withdrawal symptoms in mice: sleep, dopamine, and behavioral maladaptations

April 10th, 1:00PM MST

Dr. Kesner is the Chief of the Unit on Motivation and Arousal at National Institute on Alcohol Abuse and Alcoholism (NIAAA). The mission of his lab is to use systems neuroscience approaches to understand how brain systems controlling motivated […]

Read More »

Roberta Paris, PhD.

Genetic, molecular and biochemical studies on the accumulation of bioactive compounds in Cannabis sativa L.

19 March, 2025, 11:00 AM  

Dr. Roberta Paris studied at the Alma Mater Studiorum, University of Bologna, where she obtained the PhD in Cellular and Molecular Biology in 2006. She is a permanent researcher at Council for Agricultural Research and Economic, Research […]

Read More »

Sarah D. Lichenstein, PhD.

Neural mechanisms of risk for problem-level cannabis use among emerging adults

Dr. Lichenstein is a licensed clinical psychologist, an Assistant Professor of Psychiatry, and Assistant Director of the Yale Imaging and Psychopharmacology Lab at Yale School of Medicine. She received her BA in Psychology from Bard College (2008), and her PhD in Clinical Psychology from the […]

Read More »

Kevin Boehnke, PHD.

January 9th at 1:00PM MST

Thoughtful approaches to chronic pain and cannabis research

Dr. Kevin Boehnke is an Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. Kevin received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. He is also a […]

Read More »

David Gorelick, MD, PHD.

December 12th at 1:00PM MST

Cannabis-related psychiatric disorders

Dr. David Gorelick earned his bachelor degree in psychology from Cornell University and his medical degree and PhD in pharmacology from Albert Einstein College of Medicine. After completing his psychiatry residency at UCLA, he remained on the faculty until 1989, when he moved to the NIDA Intramural Research […]

Read More »